Objective-To examine whether reactive arthritis (ReA) known to occur after a urogenital infection with Chlamydia trachomatis can also follow an infection with Chlamydia pneumoniae, a recently described species of Chlamydiae that is a common cause of respiratory tract infections. Methods-Specific antibodies (microimmunofluorescence test) and lymphocyte proliferation to C trachomatis and C pneumoniae in paired samples of peripheral blood and synovial fluid were investigated in 70 patients with either reactive arthritis (ReA) or undifferentiated oligoarthritis (UOA). Results-Five patients with acute ReA after an infection with C pneumoniae are reported. Three had a symptomatic preceding upper respiratory tract infection and two had no such symptoms.
antigen.
In addition to C trachomatis, two species of the genus Chlamydia are known, Chlamydia psittaci and Chlamydia pneumoniae. C psittaci which can infect humans has occasionally been reported as a cause of reactive arthritis. 6 Triplicate wells were stimulated with some or all of the following agents: TCM alone (background proliferation); Chlamydia trachomatis serovar LI (5 pug/ml) and Chlamydia pneumoniae (5 ,ug/ml), grown and purified as previously described12; Yersinia enterocolitica 0 3 and 0 9 (3 ,ug/ml), grown in trypticase soya bouillon over 48 hours and washed in phosphate buffered saline (PBS); Tetanus Toxoid (1T, Behring, Marburg, Germany, 1 ,ug/ml); Pokeweed Mitogen (PWM, Sigma, Poole, UK, 1 ,ug/ml). Wells were pulsed with 3H-thymidine (0-2 ,uCi per well) for the last 18 hours of culture and incorporation measured at day 6 as previously described. 3 Optimal dose and time for proliferation assays were investigated in preliminary experiments (data not shown). Stimulation was done with whole bacteria; all bacteria were heat-inactivated for one hour at 60°C. The stimulation index (SI) was defined as proliferation to antigen divided by background proliferation.
SEROLOGY
IgG, IgM and IgA chlamydial antibodies were measured by standardised micro-immunofluorescence as previously described. 13 The following serotypes were used as antigens: Chlamydia trachomatis (serotypes A-C, D-K, L1-L3), Chlamydia pneumoniae (TWAR;
isolates TW-183 and IOL-207) and a pool of Chlamydia psittaci isolates (human 33-L and IOL-395, cat 457-F, sheep abortion A-22, pigeon SDP-247).
Results
Chlamydia pneumoniae could be identified as the triggering agent of arthritis in five of 70 (7%) patients. These five patients (clinical details see table) had antibodies specific to C pneumoniae and also an antigen-specific synovial lymphocyte proliferation was found. Three of these patients had a preceding symptomatic infection of the upper respiratory tract and two did not. All patients had oligoarthritis predominantly of the lower limbs. Two of five patients were HIA B27 positive and two negative.
SPECIFIC HUMORAL IMMUNE RESPONSE TO C pneumoniae Five patients had specific antibodies against C pneumoniae in their sera with either an IgMtitre >1/8 or an IgG-titre .1/512 indicating7 acute infection (figs IA, 2A). None of the other patients had antibody titres fulfilling these criteria. As can be seen in figure 1A there was no crossreactivity of the humoral response between C pneumoniae and C trachomatis. This was also true for patient 5 who had no anti-CT antibodies.
In comparison, none of 58 healthy controls had an IgG-titre >1/64 to any of the tested Chlamydiae and only three showed a low IgMtitre (1/8) to C trachomatis. Fifteen of these 58 (26%) and 18 of 58 (31%) had low titres of antibodies against C trachomatis serovar D-K or CPn respectively. No antibodies against C psittaci were detectable.
LYMPHOCYTE PROLIFERATION TO C pneumoniae IN PERIPHERAL BLOOD (PB)
A high lymphocyte proliferation in PB was found in patients 1 and 2, but the stimulation index was always lower in PB compared with SF ( fig 1B) . In patients 3, 4 and 5 the lymphocyte proliferation to C pneumoniae in PB was small, similar or even lower than to control antigens (figs 1 B, 2B).
SYNOVIAL LYMPHOCYTE PROLIFERATION TO Chlamydia pneumoniae The same five patients who had specific antibodies against C pneumoniae showed a C pneumoniae-specific synovial lymphocyte proliferation. This was always higher than for C trachomatis (figs 1B, 2B) which elicited the second highest response in these patients.
In patient 5 a serial investigation of synovial fluid was possible because a relapsing knee arthritis after an infection with C pneumoniae. 
respiratory tract infection due to C pneumoniae; the preceding infection can either be symptomatic or not. In our patients without preceding symptoms a high IgG titre in one and a positive IgM titre against C pneumoniae in the other suggested a recent infection with this microbe. Reportedly high IgG titres against C pneumoniae with no IgM elevation are an indication of a reinfection rather than a new infection.7 In a countrywide epidemic of C pneumoniae infection in Finland patients with high IgG-titres and no IgM-titres had a symptomatic upper respiratory tract infection also arguing against a reactivation of a persistent infection. 7 All five patients with C pneumoniae-triggered ReA had a specific antibody response and an antigen-specific synovial lymphocyte proliferation in parallel. In earlier studies we and others have shown that in ReA' 14 and Lyme arthritis,'5 a dissociation between the cellular and the humoral response to the triggering antigen can be found. Since Chlamydiae are obligate intracellular bacteria the cellular immune response is probably of major importance in Chlamydia-triggered arthritis due to the chronic persistence of this organism.6 In the acute phase of infection the humoral immune response is also important because antibodies are able to prevent spreading of the bacteria. Thus the good correlation between the humoral and the local cellular immune response in the patients in this study could be explained by all of them having an acute infection with C pneumoniae. In one patient (patient 5) an early and persistent cellular immune response to C pneumoniae in the synovial fluid was detectable (fig 2B) , at a time when specific antibodies ( fig 2A) were still absent. Hypothetically, the bacteria could have spread from the site of the initial infection to the joint before the antibodies were able to confine the pathogen to the respiratory tract.
A low cellular immune response to C pneumoniae in PB was found in three patients while it was high in the other two. This agrees with previous results with other ReAassociated bacteria which we5 and others'0 have previously reported. In some patients in the early course of ReA a lymphocyte proliferation to the triggering antigen can be detected not only in synovial fluid but also in PB. Whether there is a difference in the clinical course of arthritis in patients with a high compared with a low systemic immune response is not known.
We were able to show that the synovial lymphocyte proliferation differentiated between a cellular immune response to C trachomatis and C pneumoniae. This could also be demonstrated in two patients with C trachomatis-induced ReA (fig 3) , but needs to be confirmed in a higher number of patients. In oligoarthritis without preceding symptoms typical for ReA we, and others, have shown that the specific synovial lymphocyte proliferation to ReA-associated bacteria can indicate an ongoing cellular immune response while the antibody response is negative.5 4 The results of this study supports the argument that, in such patients, the lymphocyte proliferation assay is a valuable method for identifying triggering bacteria.
To date, only preliminary results and a case report based solely on antibodies about a possible relationship between ReA and C pneumoniae were available. '"' Our data now establish that C pneumoniae can indeed cause ReA. At present, it is not known whether ReA after infection with C pneumoniae is associated with HLA B27, spinal involvement or other features of spondylarthropathies like enthesopathy or daktylitis. In our study half of the patients with arthritis due to C pneumoniae were HLA B27 positive and one patient had enthesopathy (patient 3, table) . However, our numbers are too small to speculate on the possible associations of C pneumoniae-triggered ReA and spondylarthropathies. Also, the frequency of C pneumoniae-induced infections leading to ReA and the clinical course are not yet known and need further study. Answering these questions could be of importance, as preliminary results from studies on long term antibiotic treatment of patients with C trachomatis-induced ReA are encouraging.20
The detection of C pneumoniae-antigen in the joint would certainly provide further evidence that this microbe causes ReA. Studies are in progress with a C pneumoniae-specific polymerase chain reaction to investigate synovial fluid pellets and synovial membrane biopsies from these patients for the presence of C pneumoniae-DNA. A positive result would also back the hypothesis that bacterial antigen in the joint drives the local immune responsesimilar to ReA caused by C trachomatis,21 22 Yersinia,23 Salmonella24 and Borrelia.25
In conclusion, this study broadens the spectrum of arthritogenic bacterial agents by demonstrating that Chlamydia pneumoniae is a possible cause of ReA. Determination of specific antibodies and, where possible, measurement of the bacteria-specific synovial lymphocyte proliferation and a history of respiratory tract infection should be included in the diagnostic investigation and differential diagnosis of reactive arthritis and undifferentiated arthritis.
